We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Collection Tubes Compared for Glucose Values

By LabMedica International staff writers
Posted on 04 Apr 2013
Blood glucose concentrations in samples collected with barrier serum tubes and plasma tubes with anticoagulants have been compared. More...


Blood specimens for plasma glucose analysis have been collected in tubes which contain sodium fluoride (NaF), to prevent coagulation and glycolysis, and an inhibitor potassium oxalate (KOx) and compared with samples collected in barrier serum tubes.

Scientists at the University of Ottawa (ON, Canada) collected serum and plasma samples were under field conditions from a single draw of 3,692 individuals. Collection was performed using a 4.0 mL plasma NaF/KOx tube and a 7.5 mL serum separator tubes (SST) tube; both are from the BD Vacutainer range (Becton–Dickinson; Franklin Lakes, NJ, USA).

Plasma and serum specimens were analyzed on a Vitros 5.1 FS analyzer (Ortho-Clinical Diagnostics Inc. Raritan, NJ, USA) using the VITROS GLUSlide method, which has a multilayered, analytical element coated on a polyester support. Paired specimens from both SST and NaF/KOx draws from each respondent were analyzed using the same lot of reagent, eliminating any lot-to-lot variability in the results.

A total of 495 paired samples were used in the final comparison. There was a high rate of 86.2% hemolysis in the NaF/KOx tubes, while hemolysis was infrequently observed with only 2% the SST tubes. Comparing only blood draws where no hemolysis was observed in both tubes showed no effect of tube type on serum/plasma glucose concentrations. This was also observed when data was restricted to cases when only SST samples were not hemolyzed. The mean glucose concentrations measured in plasma was 4.85 ± 1.25 mmol/L and in serum was 4.84 ± 1.24 mmol/L, which was not significantly different.

The authors concluded that both collection tubes can be used under survey collection and processing conditions to measure glucose with this assay system with no difference in reported results. The elimination of NaF/KOx tubes would provide process and operational advantages and a significant cost saving measure for national population-based surveys. The study was published in the March 2013 issue of the journal Clinical Biochemistry.

Related Links:
University of Ottawa
Becton–Dickinson
Ortho-Clinical Diagnostics Inc.



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.